SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037204
Filing Date
2023-08-02
Accepted
2023-08-02 16:20:27
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgen-20230630.htm   iXBRL 10-Q 3728368
2 EX-31.1 rgen-ex31_1.htm EX-31.1 18126
3 EX-31.2 rgen-ex31_2.htm EX-31.2 18097
4 EX-32.1 rgen-ex32_1.htm EX-32.1 26085
  Complete submission text file 0000950170-23-037204.txt   13741415

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgen-20230630_lab.xml EX-101.LAB 577725
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgen-20230630.xsd EX-101.SCH 63610
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgen-20230630_cal.xml EX-101.CAL 58675
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgen-20230630_pre.xml EX-101.PRE 461252
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgen-20230630_def.xml EX-101.DEF 357275
78 EXTRACTED XBRL INSTANCE DOCUMENT rgen-20230630_htm.xml XML 3022292
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 231135955
SIC: 2836 Biological Products, (No Diagnostic Substances)